Spruce Biosciences Plans IPO to Advance Rare Disease Therapies
Spruce Biosciences, Inc. (SPRB), a South San Francisco–based biotech, is preparing for an initial public offering (IPO) aimed at raising fresh capital to accelerate...
Regentis Biomaterials Ltd. Prepares IPO to Advance Regenerative Medicine Solutions
Regentis Biomaterials Ltd., an Israel-based regenerative medicine company, is preparing to launch an initial public offering (IPO) under the ticker RGNT. The company has...
Legence Prices IPO at $28, Raising $728 Million in Market Debut
Lead Paragraph
Legence, an engineering and installation company focused on sustainable building solutions, has priced its initial public offering (IPO) at $28 per share, raising...
Engineering and installation company Legence prices IPO at $28, within the range
Legence, an engineering and installation services provider, has priced its initial public offering at $28 per share, landing squarely within the indicated range. The...
SPAC Meshflow Acquisition Files for a $300 Million IPO, Targeting Blockchain Infrastructure
Meshflow Acquisition, a newly formed special purpose acquisition company (SPAC), has filed to raise up to $300 million in its initial public offering, marking...
